Debt ConcernsTE's high level of debt serves as a risk, though the Dec'29 maturities/established relationship with Trina as the counterparty mitigate the risk.
Regulatory ChallengesThe company disclosed DOJ grand jury subpoenas and a parallel SEC information request regarding a director’s stock sales.
Sales Volume LimitationTE's ability to secure international, non-FEOC cells remains a gating factor to higher sales volumes estimates next year.